What is the ticker symbol for FibroGen?

FibroGen trades under the ticker FGEN on NASDAQ.

What sector does FibroGen operate in?

FibroGen is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FGEN in a portfolio?

PortView shows FGEN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

FibroGen (FGEN) Stock Analysis

NASDAQHealthcareBiotechnology

$9.07-1.63%

1-year price historyRange $5.16 – $19.31

52-week range$9.07

$4.85$21.95

What FibroGen does

FibroGen, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and bringing to market therapies that address significant medical conditions currently lacking effective treatments. Among its pipeline, FibroGen is advancing Roxadustat, an orally administered small molecule that inhibits hypoxia inducible factor prolyl hydroxylases. This drug has successfully completed Phase III clinical trials in the US, Europe, China, and Japan for treating anemia in chronic kidney disease, and is currently in Phase II/III development in China for anemia linked to myelodysplastic syndromes. Additionally, the company is progressing Pamrevlumab, a human monoclonal antibody designed to block connective tissue growth factor. Pamrevlumab is undergoing Phase III clinical development for multiple conditions including idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, with a separate Phase III trial also underway for Duchenne muscular dystrophy. FibroGen maintains strategic collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. Established in 1993, FibroGen, Inc. operates from its headquarters in San Francisco, California.

Key metrics

Market cap

$36.69M

P/E (TTM)

-0.71

EPS (TTM)

$-12.85

Beta

0.77

Dividend yield

0.00%

Revenue / share

$1.14

50-day avg

$9.14

200-day avg

$8.84

52-week high

$21.95

52-week low

$4.85

CEO

Thane Wettig

ETFs linked to FGEN

Broad-market and Healthcare sector ETFs an investor holding FibroGen is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how FGEN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze FGEN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for FibroGen?: FibroGen trades under the ticker FGEN on NASDAQ.
Which exchange is FGEN listed on?: FGEN is listed on NASDAQ.
What sector does FibroGen operate in?: FibroGen is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze FGEN in a portfolio?: PortView shows FGEN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.